Contrast study between budesonide inhalation with methylperdnisolone intravenous in the treatment of acute exacerbation of chronic obstructive pulmonary disease
10.3760/cma.j.issn.1008-6706.2013.04.008
- VernacularTitle:布地奈德吸入与甲泼尼龙静脉应用治疗慢性阻塞性肺疾病急性加重期的对比研究
- Author:
Wei WANG
;
Qiufen XU
- Publication Type:Journal Article
- Keywords:
Pulmonary disease,chronic obstructive;
Budesonide;
Methylprednisolone
- From:
Chinese Journal of Primary Medicine and Pharmacy
2013;20(4):499-501
- CountryChina
- Language:Chinese
-
Abstract:
Objective To compare the effect and safety between budesonide inhalation with methylperdnisolone intravenous in the treatment of acute exacerbation of chronic obstructive pulmonary disease(AECOPD).Methods 80 patients with AECOPD were divided into the control group and observation group randomly,each group 40 cases.Based on regular treatment,the patients in the control group received intravenous treatment of methylprednisolone,while patients in the observation group receive inhaled treatment of budesonide.The near-term and long-term effect,symptom score,and the indicators such as FEV1/FVC,MMEF,PaO2,PaCO2 and AHR were observed and compared beween the two groups before and after treatment.Results Compared with control group,there were no significant differences of short-term and long term treatment effects and symptom score in observation group(all P ＞ 0.05) ;The indicators of pulmonary function and blood gas analysis improved significantly in all patients after treatments(all P ＜ 0.05),but there were no significant differences between two groups(all P ＞0.05) ;The incidence of side effects in observation group was significantly lower than that of control group (P ＜ 0.05).Conclusion Glucocorticoid in the treatment of AECOPD has clear effect,and regardless of the mode of administration,it has good near-term and longterm effect.But in adverse reactions budesonide inhalation is significantly superior to methylprednisolone intravenous therapy.
